59.46USDMkt Cap: 121.42B USDP/E: 16.66Last update: 2026-05-22
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neu…
Industry Peers
Drug Manufacturers - Generalloading…
Indicators:|
Key Statistics
Company
Market Cap121.42B USD
Enterprise Value157.58B USD
Revenue (TTM)48.48B USD
Gross Profit34.26B USD
Net Income (TTM)7.05B USD
Revenue/Share23.82 USD
Last Price59.46 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees32.5K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)16.66
P/E (Forward)9.65
PEG185.55
EV/EBITDA8.30
EV/Revenue3.25
P/S2.51
P/B6.06
EPS (TTM)3.57
EPS (Forward)6.17
52W Range
59.2521% of range60.25
52W High60.25 USD
52W Low59.25 USD
Profitability
Gross Margin71.08%
Oper. Margin33.04%
EBITDA Margin39.14%
Profit Margin14.64%
ROE38.19%
ROA7.83%
Growth
Revenue Growth2.60%
Earnings Growth9.20%
Cash Flow & Leverage
Operating CF14.16B USD
CapEx (TTM)1.31B USD
FCF Margin20.32%
FCF Yield8.11%
Net Debt35.94B USD
Net Debt/EBITDA1.89
Balance Sheet
Debt/Equity2.55
Current Ratio1.42
Quick Ratio1.18
Book Value/Sh9.828 USD
Cash/Share5.135 USD
Dividends
Fwd Div Rate2.520 USD
Trail. Div Rate2.500 USD
Div. Yield4.23%
5Y Avg Yield3.93%
Payout Ratio70.03%
Ex-Div DateApr 2, 2026
Pay DateMay 1, 2026
Splits
Last Split1000000:951777
Split DateAug 7, 2001
Analyst Consensus
Rating2.5 (Hold)
Target (Mean)62.96 USD
Target Range40.00 USD – 75.00 USD
# Analysts25
Ownership
Shares Out.2.04B
Float2.04B
Insiders0.08%
Institutions83.89%
Short Interest
Short Ratio3.1d
Short % Float1.53%
Short % Out.1.53%
Shares Short31.33M
Short (prev mo.)31.50M
Technical
SMA 5058.39 (+1.8%)
SMA 20052.72 (+12.8%)
Beta0.26
S&P 52W Chg28.31%
Avg Vol (30d)5.16M
Avg Vol (10d)9.09M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—